Pharmacoadherence: A new term for a significant problem

American Journal of Health-System Pharmacy

Volumn 65, Issue 7, 2008, Pages 661-667

  Chisholm Burns, Marie A ^a   Spivey, Christina A ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ASSESSMENT; DIET; EXERCISE; HEALTH CARE COST; HEALTH CARE PERSONNEL; MEDICAL SOCIETY; NOTE; PATIENT COMPLIANCE; PHARMACOADHERENCE; PRIORITY JOURNAL; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 41749123033     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070372     Document Type: Note

References (72)

1. World Health Organization. Adherence to long-term therapies. Evidence for action. 2003. www.emro.who.int/ncd/Publications/adherence_report.pdf (accessed 2007 Jun 20).
2. Van Dulman S, Sluijs E, van Dijk L et al. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res. 2007; 7:55.
3. Modi AC, Lim CS, Yu N et al. A multi-method assessment of treatment adherence for children with cystic fibrosis. J Cyst Fibros. 2006; 5:177-85.
4. Balfour L, Kowal J, Silverman A et al. A randomized controlled psycho-education intervention trial: improving psychological readiness for successful HIV medication adherence and reducing depression before initiating HAART. AIDS Care. 2006; 17:830-8.
5. Kruse W, Weber E. Dynamics of drug regimen compliance: its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol. 1990; 38:561-5.
6. Luscher TF, Vetter H, Siegenthaler W et al. Compliance in hypertension: facts and concepts. J Hypertens. 1985; 3:3-9.
7. DiMatteo MR. Variations in patients' adherence to medical recommendations. A quantitative review of 50 years of research. Med Care. 2004; 42:200-9.
8. Cramer JA, Mattson RH, Prevey ML et al. How often is medication taken as prescribed? JAMA. 1989; 261:3273-7.
9. De Klerk E, van der Linden S. Compliance monitoring in NSAID drug therapy in ankylosing spondylitis, experiences with an electronic monitoring device. Br J Rheumatol. 1996; 35:60-5.
10. Simoni JM, Frick PA, Huang B. A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychology. 2006; 25:74-81.
11. DeGeest S, Borgermans L, Gemoets H et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation. 1995; 59:340-7.
12. DiMatteo M, Giordani P, Lepper H et al. Patient adherence and medical treatment outcomes. Med Care. 2002; 40:794-811.
13. Simpson SH, Eurich DT, Majumdar SR et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006; 333:15.
14. Berg JS, Dischler J, Wagner DJ et al. Medication compliance: a healthcare problem. Ann Pharmacother. 1993; 27:S1-24.
15. Sabate E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003:1-211.
16. Lutfey KE, Wishner WJ. Beyond "compliance" is "adherence." Diabetes Care. 1999; 22:635-9.
17. Velligan DI, Lam YF, Glahn DC et al. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull. 2007; 32:724-42.
18. Bennett Johnson S. Methodological issues in diabetes research. Diabetes Care. 1992; 15:1658-67.
19. Stimson GV. Obeying doctor's orders: a view from the other side. Soc Sci Med. 1974; 8:97-104.
20. Chatterjee JS. From compliance to concordance in diabetes. J Med Ethics. 2006; 32:507-10.
21. Barber N. Should we consider noncompliance a medical error? Qual Saf Health Care. 2002; 11:81-4.
22. Huffman MH. Compliance, health outcomes, and partnering in PPS. Acknowledging the patient's agenda. Home Healthc Nurs. 2005; 23:23-8.
23. Schechter CB, Walker EA. Improving adherence to diabetes self-management recommendations. Diabetes Spectrum. 2002; 15:170-5.
24. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999; 21:1074-90.
25. Partridge AH, Avorn J, Wang PS et al. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst. 2002; 94:652-61.
26. Hill J. Adherence with drug therapy in the rheumatic diseases. Part two: measuring and improving adherence. Musculoskeletal Care. 2005; 3:143-56.
27. Liu H, Golin CE, Miller LG et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001; 134:968-77.
28. Butler JA, Peveler RC, Roderick P et al. Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring. Transplantation. 2004; 77:786-9.
29. Miller LG, Hays RD. Measuring adherence to antiretroviral medications in clinical trials. Hiv Clin Trials. 2000; 1:36-46.
30. Smith SR, Wahed AS, Kelley SS et al. Assessing the validity of self-reported medication adherence in hepatitis C treatment. www.theannals.com/cgi/reprint/aph.1K024vl (accessed 2007 Jun 11).
31. Byerly MJ, Thompson A, Carmody T et al. Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatr Serv. 2007; 58:844-7.
32. Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med. 1994; 149:569-76.
33. Braam RL, van Uum SH, Russel FG et al. Bromide as a marker to measure adherence to drug therapy. Eur J Clin Pharmacol. 2006; 62:285-90.
34. Dunbar J. Adherence measures and their utility. Control Clin Trials. 1984; 5:515-21.
35. Hearnshaw H, Lindenmeyer A. What do we mean by adherence to treatment and advice for living with diabetes? A review of the literature on definitions and measurements. Diabet Med. 2005; 23:720-8.
36. Wagner GJ, Ghosh-Dastidar B. Electronic monitoring: adherence assessment or intervention? HIV Clin Trials. 2002; 3:45-51.
37. Wagner GJ, Rabkin JG. Measuring medication adherence: are missed doses reported more accurately than perfect adherence? AIDS Care. 2000; 12:405-8.
38. Wendel CS, Mohler MJ, Kroesen K et al. Barriers to use of electronic adherence monitoring in an HIV clinic. Ann Pharmacother. 2001; 35:1010-5.
39. Lee J, Krusek J, Greene P et al. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) pilot study. Am J Hypertens. 1996; 9:719-25.
40. Choo PW, Rand CS, Inui TS et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999; 37:846-57.
41. Wetzels GE, Schouten JS, Dirksen CD et al. Electronic monitoring of adherence as a tool to improve blood pressure control. Am J Hypertens. 2007; 20:119-25.
42. Jasti S, Siega-Riz AM, Cogswell ME et al. Correction for errors in measuring adherence to prenatal multivitamin/mineral supplement use among low-income women. J Nutr. 2006; 136:479-83.
43. Schlenk EA, Dunbar-Jacob J, Engberg S. Medication non-adherence among older adults. J Gerontol Nurs. 2004; 30:33-43.
44. Lee JK, Grace KA. How should we measure medication adherence in clinical trials and practice? J Am Pharm Assoc. 2006; 46:420,423.
45. Kalichman SC, Amaral CM, Stearns H et al. Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. J Gen Intern Med. 2007; 22:1003-6.
46. Grosset KA, Bone I, Reid JL et al. Measuring therapy adherence in Parkinson's disease: a comparison of methods. J Neurol Neurosurg Psychiatry. 2006; 77:249-51.
47. Hess LM, Raebel MA, Conner DA et al. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006; 40:1280-8.
48. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997; 50:105-16.
49. Fairley CK, Permana A, Read TR. Long-term utility of measuring adherence by self-report compared with pharmacy records in a routine clinic setting. HIV Med. 2005; 6:366-9.
50. Prado JC Jr., Krupek E, Mion D Jr. Validity of four indirect methods to measure adherence in primary care hypertensives. J Hum Hypertens. 2007; 21:579-84.
51. Mannheimer SB, Mukherjee R, Hirschhorn LR et al. The CASE adherence index: a novel method for measuring adherence to antiretroviral therapy. AIDS Care. 2006; 18:853-61.
52. Chisholm MA. Enhancing patients' adherence to medication therapy. Clin Transplant. 2002; 16:30-8.
53. Heneghan CJ, Glasziou P, Perera R. Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Syst Rev. 2006; 25:CD005025.
54. Iskedjian M, Einarson TR, MacKeigan LD et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther. 2002; 24:302-16.
55. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions. Arch Intern Med. 2007; 167:540-50.
56. Gallefoss F, Bakke PS. How does patient education and self-management among asthmatics and patients with chronic pulmonary disease affect medication? Am J Respir Crit Care Med. 1999; 160:2000-5.
57. Friedman RH, Kazis LE, Jette A et al. A telecommunication system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens. 1996; 9:285-92.
58. Rigsby MO, Rosen MI, Beauvais JE et al. Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. J Gen Intern Med. 2000; 15:841-7.
59. Dolder CR, Lacro JP, Leckband S et al. Interventions to improve antipsychotic medication adherence: review of recent literature. J Clin Psychopharmacol 2003; 23:389-99.
60. Kirscht JP, Kirscht JL, Rosenstock IM. A test of interventions to increase adherence to hypertensive medical regimens. Health Educ Q. 1981; 8:261-72.
61. Broadhead H, Heckathorn DD, Altice FL et al. Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study. Soc Sci Med. 2002; 55:235-46.
62. Knobel H, Carmona A, López JL et al. Adherence to very active antiretroviral treatment: impact of individualized assessment. Enferm Infecc Microbiol Clin. 1999; 17:78-81.
63. Roter DL, Hall JA, Merisea R et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998; 36:1138-61.
64. McDonald HP, Garg AX, Hayner RB. Interventions to enhance patient adherence to medication prescriptions. JAMA. 2002; 288:2868-79.
65. Haynes R, Yao X, Degani A et al. Interventions to enhance medication adherence. Cochrane Database Syst Rev. 2005; 19:CD000011.
66. Vergouwen AC, Bakker A, Katon WJ et al. Improving adherence to antidepressants: a systematic review of interventions. J Clin Psychiatry. 2003; 64:1415-20.
67. Van Eijken M, Tsang S, Wensing M et al. Interventions to improve medication compliance in older patients living in the community. Drugs Aging. 2003; 20:229-40.
68. Higgins N, Regan C. A systematic review of the effectiveness of interventions to help older people adhere to medication regimens. Age Ageing. 2004; 33:224-9.
69. Hamilton GA. Measuring adherence in a hypertension clinical trial. Eur J Cardiovasc Nurs. 2003; 2:219-28.
70. Haynes RB, McKibbon KA, Kanani R. Systematic reviews of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996; 348:383-6.
71. American Public Health Association. Adherence to HIV treatment regimens. Recommendations for best practices. 2004. www.apha.org/NR/rdonlyres/A030DDB1- 02C8-4D80-923B-7EF6608D62F1/0/BestPracticesnew.pdf (accessed 2007 Jun 20).
72. American Psychological Association. Testimony of the American Psychological Association submitted to the U.S. Senate Committee on Labor and Human Resources on the subject of adherence to HIV/AIDS drug therapy. 1997. www.apa.org/ppo/issues/paids.html (accessed 2007 Jun 20).